Pulsatility of insulin release--a clinically important phenomenon

Area of Science:

• Endocrinology
• Cellular Physiology
• Metabolic Regulation

Background:

• Pancreatic beta-cells exhibit intrinsic oscillatory behavior, crucial for pulsatile insulin release.
• Interactions within and between islets of Langerhans, involving gap junctions and signaling molecules like ATP, synchronize these oscillations.
• Neural regulation, including acetylcholine and ATP, further coordinates islet activity for rhythmic hormone secretion.

Purpose of the Study:

• To elucidate the mechanisms underlying pulsatile insulin release and its clinical significance.
• To investigate the role of purinergic signaling (P2Y1 and adenosine A1 receptors) in regulating pulsatile secretion of insulin, glucagon, and somatostatin.
• To compare findings in rodent models with human islets and inform therapeutic strategies.

Main Methods:

• Studies on perfused rat and mouse pancreas to analyze hormone secretion patterns.
• Utilized pharmacological inhibitors (P2Y1 receptor antagonist) and genetic manipulation (adenosine A1 receptor knock-out).
• Analysis of hormone secretion from isolated human islets.

Main Results:

• Glucose induces anti-synchronous pulses of insulin, glucagon, and somatostatin, with somatostatin potentially mediating alpha-cell paracrine regulation.
• P2Y1 receptor inhibition abolished glucagon and somatostatin pulses while preserving insulin pulses.
• Adenosine A1 receptor knock-out prolonged glucagon and somatostatin pulses but not insulin pulses, indicating specific roles in hormone regulation.

Conclusions:

• Purinergic signaling via P2Y1 and adenosine A1 receptors is critical for the coordinated, pulsatile release of islet hormones.
• The observed anti-synchrony between insulin and glucagon is vital for regulating hepatic glucose production.
• Current pulsatile intravenous insulin infusion therapy (PIVIT) protocols should be refined to replicate the natural anti-synchronous hormone release patterns.